Chemfab Alkalis FY26: Standalone Profit ₹7.51 Cr, Consolidated Loss ₹3.43 Cr; ₹1.25 Dividend Proposed

Chemfab Alkalis Ltd reported its audited financial results for the fiscal year ended March 31, 2026. Standalone revenue reached ₹288.57 crore with a standalone net profit of ₹7.51 crore. However, the company reported a consolidated net loss of ₹3.43 crore for the same period against consolidated revenues of ₹311.02 crore.

Financial Results and Board Actions

The Board of Directors approved the audited standalone and consolidated financial results for FY26. Standalone operations reported a net profit of ₹7.51 crore on revenue of ₹288.57 crore. Consolidated results showed a net loss of ₹3.43 crore against revenue of ₹311.02 crore. A final dividend of ₹1.25 per share was recommended, pending shareholder approval. M/s. Madhavan, Mohan & Associates were reappointed as Cost Auditors, and M/s. Brahmayya & Co. were reappointed as Internal Auditors for FY27. The company confirmed its status as "Not a Large Corporate" under SEBI guidelines. Outstanding borrowings were ₹81.43 crore, with a credit rating of IND BBB+/Negative.

Key Takeaways

The contrast between its standalone profit and consolidated loss points to challenges within the company's broader group or subsidiaries. The recommended ₹1.25 per share dividend offers a direct return to shareholders, a positive signal against the consolidated results. Confirming its "Not a Large Corporate" status can ease regulatory burdens and save resources. The 'Negative' credit rating outlook signals potential future financial pressures.

Company Background

Chemfab Alkalis Ltd. manufactures chlor-alkali products like caustic soda, liquid chlorine, and hydrochloric acid. These are essential for industries such as textiles, paper, and pharmaceuticals. Chemfab Alkalis has historically reported consolidated net losses, often due to its subsidiaries' performance, even while its standalone operations remain profitable. The company carries significant outstanding borrowings, which impact its financial costs and leverage. SEBI's "Large Corporate" rules impose specific disclosure and compliance requirements on large listed companies. Chemfab Alkalis's current status exempts it from these.

Next Steps and Outlook

Shareholders must approve the ₹1.25 per share final dividend at the upcoming Annual General Meeting. Reappointing cost and internal auditors ensures continuity in financial oversight for the coming year. Its "Not a Large Corporate" status could offer more operational and compliance flexibility. Investors will assess whether standalone profits can offset consolidated losses and the implications of the credit rating outlook.

Key Risks and Concerns

The consolidated net loss for FY26 signals ongoing challenges within the company's group structure or its operational entities. India Ratings & Research's 'Negative' credit outlook signals potential concerns about the company's future financial health and its ability to meet obligations. Significant borrowings of ₹81.43 crore expose the company to interest rate volatility and refinancing risks.

Comparison with Industry Peers

Major chlor-alkali peers like GHCL Ltd and Gujarat Alkalies and Chemicals Ltd (GACL) reported stronger consolidated profits for FY24, ₹356 crore and ₹1,300 crore respectively. DCW Ltd, also in basic chemicals including chlor-alkali, posted a consolidated profit of ₹120 crore for FY24. Chemfab's consolidated performance contrasts with these peers, highlighting distinct company-specific pressures.

Future Watchlist

• Shareholder approval of the ₹1.25 dividend at the AGM.
• Management's explanation for the consolidated loss and their strategy to resolve it.
• Updates regarding the IND BBB+/Negative credit rating.
• Input cost trends and demand for chlor-alkali products.
• Ability to service debt given current borrowings and credit outlook.
• Implications of "Not a Large Corporate" status on future strategy or capital raising.